Director of Program and Alliance Management

The Director of Program and Alliance Management position is a high impact, hands-on leadership role with responsibility for significant elements of program strategy and alliance management.  This role requires a talented individual with proven expertise in scientific evaluation and portfolio management. 

With a focus across both academia and industry, the Director of Program and Alliance Management will also provide deep pre-clinical and/ or clinical scientific leadership to Sumitomo Dannipon Pharma Oncology’s global sourcing of scientific innovation, partnership opportunities in the oncology therapeutic area, as well as leadership in the technical evaluation and due diligence of oncology in-licensing, acquisition, and/or NewCo formation opportunities at all stages of development, to feed our future pipeline. 

The focus of this role is on scientific evaluation, program management vs business development.

Responsibilities

  • Monitor and track program budget with finance team and Sumitomo Dainippon Pharma in Japan, escalate significant budget changes; advocate for additional resources when needed for program success.
  • Ability to prioritize assets and manage timelines cross-functionally.
  • Assists in planning and execution of Scientific and Venture Capital Summits, to include invitation of KOLs, VCs, Scientific Leaders and Japanese Stakeholders.
  • Alliance Management: Act as key point of contact with academia/ industry, drive research project/ integration of partner’s platform/ IND/ early-stage clinical assets internally, and ensure partner achieves agreed upon milestones.
  • Responsible for on-time project completion within the approved budget and for providing frequent updates on progress towards objectives and achievement of milestones of partner-led projects to ensure timely delivery, highlighting any issues that might adversely impact overall business plans / timelines.
  • Sets metrics, goals, develops standard templates for assessments, and criteria for initiation/ development of external partnerships in oncology.
  • Preparation of document or dashboard that captures current assets being evaluated; to also include, Clinical Data, Pre-Clinical Data, Commercial updates and IP assessment.
  • Strong program management skills required.
  • Works externally with academia/ VC-backed startups, scientific leaders, KOL, Principal Investigators and CSO to evaluate their portfolio for co-development, in-licensing, and/or NewCo formation.
  • Sourcing, leading scientific due diligence of platforms, early stage preclinical/ clinical assets, partner discussion leading to deal closure (deal sheet).
  • Accountable for the development of a comprehensive and timely due diligence package to include a full assessment (scientific evaluation, regulatory, CMC, manufacturing, clinical development, competitive landscape) of external opportunities, and make recommendations for approval.
  • Provides scientific domain expertise in oncology (discovery, preclinical to IND filing) and subject matter expertise across wide platforms (immunotherapy, Immuno-oncology, microbiome, oncolytic virus, RNAi, cancer vaccines, gene & cell therapy).
  • Drive effective and impactful communication related to program strategy in order to ensure active management of issues/risks/decisions/opportunities related to all internal and external activities
  • Works cross-functionally and builds strong and effective working relationships (R&D, manufacturing, IP, legal, marketing, finance, cancer institute Japan).
  • Other duties as assigned

Qualifications

  • PhD in immuno-oncology, immunotherapy, gene & cell therapy, and/or oncology.
  • Strong domain expertise in the oncology therapeutic area (discovery, preclinical to IND filing) is required, along with deep scientific/ technical expertise in immunotherapy/ platforms related to oncology.
  • Minimum 10 years of experience in scientific licensing in large pharma / biotech with focus on external research and innovations in biotherapeutics from discovery to clinical development.
  • In-depth understanding of the drug development process, cell therapies, biologics, and peptide platforms in oncology is required.
  • Expertise across wide platforms is required (immunotherapy, Immuno-oncology, microbiome, oncolytic virus, RNAi, cancer vaccines, gene & cell therapy).
  • Broad experience with innovations, new technology platforms, and IP.
  • Demonstrated experience in planning, prioritizing, implementation and analysis of externally driven research programs.
  • Strong communication skills, written and verbal, and ability to effectively communicate the science to management and with partners.
  • Strong interpersonal skills, with demonstrated ability to work in a multi-disciplinary setting, foster and nurture teamwork, and act as a facilitator to drive fulfillment of corporate strategic goals.
  • Although this position is not a business development role, it requires a well-developed business acumen (CDA, MTA, market analysis, budgeting, VC, alliance management).
  • Willingness to travel up to 25% to academic, industry, client and/or partner sites.
  • Comfortable with ambiguity and embracing of change.

 

Job Location: Cambridge, MA

Please send resumes to talentacquisition@bostonbiomedical.com

Equal Opportunity Employer

California residents, please visit www.SDPOncology.com/CAprivacynotice for information on our privacy practices.